Tumor Immunotherapy
Targeted Cancer Therapies
Treatment Resistent Cancers
Kidney Transplant II: Surgical Procedure
Urinary Tract Calculi VI: Surgical Management
Treatment Resistant Cancers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 22, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
1Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA derek.raghavan@carolinashealthcare.org.
No abstract available in PubMed .